ReviewTherapeutic advances in hematology2022

Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myeloma.

Despina Fotiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.